Search

everythinglearnresearchcommunity

for

Search:↓

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

The skin produces and processes hormones, affecting both local and overall body functions.

Skin reactions from cancer treatments might predict how well the treatments work.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Insulinomas and adrenocortical tumors are common in older ferrets, diagnosed with blood tests and ultrasounds, and treated with medications or surgery.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Letrozole reduces seizures but not brain damage in mice.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Androgen use may increase the risk of stroke, but more research is needed.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Bicalutamide may help treat female pattern hair loss.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.